Adenosine (9-β-D-ribofuranosyladenine, Adenine riboside, Adenine-9-β-D-ribofuranoside) [58-61-7]

Référence A0869-100g

Conditionnement : 100g

Marque : US Biological



A0869 Adenosine (9-β-D-ribofuranosyladenine, Adenine riboside, Adenine-9-β-D-ribofuranoside)

Grade
Molecular Biology Grade
Shipping Temp
RT
Storage Temp
4°C

In the extracellular space,
ecto-5′-nucleotidase (CD73) dephosphorylates adenosine triphosphate (ATP) to produce adenosine. Adenosine has four receptors namely A1R, A2AR A2BR and A3R. Adenosine plays a key role in the osteogenic differentiation. A1R induces osteoclast differentiation and A2AR induces osteoblast differentiation.

Adenosine has been used:
• as a supplement in embryonic type culture medium for in vitro osteogenic differentiation
• for evaluation of its effect on cell survival by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT assay) and cell proliferation by 3H-thymidine incorporation assay in multi drug resistant glioblastoma stem-like cells (GSCs), and as a standard in high performance liquid chromatography (HPLC).
• as a constituent in collagenase solution for the collagenase digestion of mice fat tissue.

Synonyms:
9-β-D-Ribofuranosyl-9H-purin-6-amine; 9-β-D-Ribofuranosyladenine; Adenine Riboside; Adenocard; Adenocor; Adenogesic; Adenoscan; Adrekar; Boniton; D-Adenosine; 1-(6-Amino-9H-purin-9-yl)-1-deoxy-β-D-ribofuranose; Myocol; NSC 7652

CAS No:
58-61-7

Molecular Formula:
C10H13N5O4

Molecular Weight:
267.25

Purity (HPLC):
≥99%

Appearance:
White to off-white powder

Melting Point:
230-234°C

Specific Optical Rotation:
-68.0º to -73º

Storage and Stability:
Store at 4°C. Stable for 12 months after receipt.

Applications
Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. ||Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.
References
1. Long, X., et al.: J. Pharmacol. Exper. Ther., 335:781 (2010); 2. Ham, M., et al.: J. Pharmacol. Exper. Ther., 335:607 (2010)

Vous serez peut-être également intéressé par les produits suivants :



Référence
Description
Cond.
Prix HT